Cleared Traditional

KWIK-LAC BETA-LACTAMASE KITS (K811442) - FDA 510(k) Clearance

K811442 · Windsor Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1981
Decision
27d
Days
-
Risk

K811442 is an FDA 510(k) clearance for the KWIK-LAC BETA-LACTAMASE KITS.

Submitted by Windsor Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on June 18, 1981 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Windsor Laboratories, Inc. devices

Submission Details

510(k) Number K811442 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 22, 1981
Decision Date June 18, 1981
Days to Decision 27 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 88d · This submission: 27d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code -
Device Class -